These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 11678591)

  • 1. Reduction of Cr (VI) by cysteine: significance in human lymphocytes and formation of DNA damage in reactions with variable reduction rates.
    Quievryn G; Goulart M; Messer J; Zhitkovich A
    Mol Cell Biochem; 2001 Jun; 222(1-2):107-18. PubMed ID: 11678591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-oxidative mechanisms are responsible for the induction of mutagenesis by reduction of Cr(VI) with cysteine: role of ternary DNA adducts in Cr(III)-dependent mutagenesis.
    Zhitkovich A; Song Y; Quievryn G; Voitkun V
    Biochemistry; 2001 Jan; 40(2):549-60. PubMed ID: 11148050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reductive metabolism of Cr(VI) by cysteine leads to the formation of binary and ternary Cr--DNA adducts in the absence of oxidative DNA damage.
    Zhitkovich A; Shrager S; Messer J
    Chem Res Toxicol; 2000 Nov; 13(11):1114-24. PubMed ID: 11087433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reductive activation with cysteine represents a chromium(III)-dependent pathway in the induction of genotoxicity by carcinogenic chromium(VI).
    Zhitkovich A; Quievryn G; Messer J; Motylevich Z
    Environ Health Perspect; 2002 Oct; 110 Suppl 5(Suppl 5):729-31. PubMed ID: 12426121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotoxicity and mutagenicity of chromium(VI)/ascorbate-generated DNA adducts in human and bacterial cells.
    Quievryn G; Peterson E; Messer J; Zhitkovich A
    Biochemistry; 2003 Feb; 42(4):1062-70. PubMed ID: 12549927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction with glutathione is a weakly mutagenic pathway in chromium(VI) metabolism.
    Guttmann D; Poage G; Johnston T; Zhitkovich A
    Chem Res Toxicol; 2008 Nov; 21(11):2188-94. PubMed ID: 18808157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of chromium(VI) by thiols results in chromium(V) formation, chromium binding to DNA and altered DNA conformation.
    Borges KM; Boswell JS; Liebross RH; Wetterhahn KE
    Carcinogenesis; 1991 Apr; 12(4):551-61. PubMed ID: 1849467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model reactions of Cr (VI) with DNA mediated by thiol species.
    Krepkiy D; Antholine WE; Myers C; Petering DH
    Mol Cell Biochem; 2001 Jun; 222(1-2):213-9. PubMed ID: 11678605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower mutagenicity but higher stability of Cr-DNA adducts formed during gradual chromate activation with ascorbate.
    Quievryn G; Messer J; Zhitkovich A
    Carcinogenesis; 2006 Nov; 27(11):2316-21. PubMed ID: 16714765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicological Antagonism among Welding Fume Metals: Inactivation of Soluble Cr(VI) by Iron.
    Krawic C; Zhitkovich A
    Chem Res Toxicol; 2018 Nov; 31(11):1172-1184. PubMed ID: 30362728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical mechanisms of DNA damage by carcinogenic chromium(VI).
    Krawic C; Zhitkovich A
    Adv Pharmacol; 2023; 96():25-46. PubMed ID: 36858775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo effects of ascorbate and glutathione on the uptake of chromium, formation of chromium(V), chromium-DNA binding and 8-hydroxy-2'-deoxyguanosine in liver and kidney of osteogenic disorder shionogi rats following treatment with chromium(VI).
    Yuann JM; Liu KJ; Hamilton JW; Wetterhahn KE
    Carcinogenesis; 1999 Jul; 20(7):1267-75. PubMed ID: 10383900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of glutathione on chromium-induced DNA crosslinking and DNA polymerase arrest.
    O'Brien T; Xu J; Patierno SR
    Mol Cell Biochem; 2001 Jun; 222(1-2):173-82. PubMed ID: 11678599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of the amino acid-DNA complexes by hexavalent and trivalent chromium in vitro: importance of trivalent chromium and the phosphate group.
    Zhitkovich A; Voitkun V; Costa M
    Biochemistry; 1996 Jun; 35(22):7275-82. PubMed ID: 8679557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms.
    O'Brien TJ; Ceryak S; Patierno SR
    Mutat Res; 2003 Dec; 533(1-2):3-36. PubMed ID: 14643411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinogenic chromium(VI) induces cross-linking of vitamin C to DNA in vitro and in human lung A549 cells.
    Quievryn G; Messer J; Zhitkovich A
    Biochemistry; 2002 Mar; 41(9):3156-67. PubMed ID: 11863455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for molecular oxygen in the formation of DNA damage during the reduction of the carcinogen chromium (VI) by glutathione.
    Kortenkamp A; Casadevall M; Faux SP; Jenner A; Shayer RO; Woodbridge N; O'Brien P
    Arch Biochem Biophys; 1996 May; 329(2):199-207. PubMed ID: 8638952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione and free amino acids form stable complexes with DNA following exposure of intact mammalian cells to chromate.
    Zhitkovich A; Voitkun V; Costa M
    Carcinogenesis; 1995 Apr; 16(4):907-13. PubMed ID: 7728973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of chromium(VI) by ascorbate leads to chromium-DNA binding and DNA strand breaks in vitro.
    Stearns DM; Kennedy LJ; Courtney KD; Giangrande PH; Phieffer LS; Wetterhahn KE
    Biochemistry; 1995 Jan; 34(3):910-9. PubMed ID: 7827049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular and extracellular factors influencing Cr(VI) and Cr(III) genotoxicity.
    Sobol Z; Schiestl RH
    Environ Mol Mutagen; 2012 Mar; 53(2):94-100. PubMed ID: 22020802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.